8-K/A
Current Report
C4 Therapeutics, Inc. Filed Acc 0001628280-22-025322
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading cccc-20220622.htm…